Evzio(r) Naloxone Hcl
NDC Package 51662-1495-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Evzio(r) Naloxone Hcl is eVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients.EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present.EVZIO is not a substitute for emergency medical care. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1495 and is authorized under FDA application NDA209862.

Identification & Billing

NDC Package Code
51662-1495-1
Package Description
2 DOSE PACK in 1 CARTON / .4 mL in 1 DOSE PACK
Product Code
51662-1495
11-Digit Billing Format
51662149501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Evzio(r) Naloxone Hcl
Dosage Form
-
Usage Information
EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients.EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present.EVZIO is not a substitute for emergency medical care.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co Llc, Dba Healthfirst
FDA Application #
NDA209862
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-11-2020
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1495-1 identifies a specific commercial package of 2 dose pack in 1 carton / .4 ml in 1 dose pack of Evzio(r) Naloxone Hcl, labeled by Hf Acquisition Co Llc, Dba Healthfirst. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on January 11, 2020. The current certification is valid through December 31, 2024.

How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662149501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1495-1
11-Digit CMS (5-4-2)
51662-1495-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.